Yogesh Butta
About Yogesh Butta
Data last updated:
Yogesh Butta is a Cfo at Cellcronic Technologies Limited (since 2025). The companies operate in Pharma and Business Services. Cellcronic Technologies Limited reported revenue of ₹25.99 Cr (FY 2025). Earlier, Yogesh Butta was a Director at Liquid Gold Pharmaceuticals Private Limited (2020–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cellcronic Technologies Limited U51900HR2019PLC080744 | Cfo | 25 Nov 2025 | 2019 | ₹25.99 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Liquid Gold Pharmaceuticals Private Limited U74999DL2019PTC345357 | Director | 09 Nov 2020 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Yogesh Butta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjali Sheoran | 10441004 | Cellcronic Technologies Limited | Director |
| Ankur Sharma | 10260305 | Cellcronic Technologies Limited | Director |
| Deepak | 07223013 | Cellcronic Technologies Limited | Whole-Time Director |
| Ravinder Mandhan | 08473256 | Cellcronic Technologies Limited | Managing Director |
| Renu Kaur | 10080402 | Cellcronic Technologies Limited | Director |
| Sumit Sharma | Cellcronic Technologies Limited | Cfo | |
| Vinod Kumar | 11140279 | Cellcronic Technologies Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yogesh Butta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yogesh Butta
Yogesh Butta currently holds 1 directorship: Cellcronic Technologies Limited (Cfo, since 25 Nov 2025, revenue ₹25.99 Cr (FY 2025)).
Yogesh Butta was first appointed on 09 Nov 2020 as Director at Liquid Gold Pharmaceuticals Private Limited. The most recent appointment on record is 25 Nov 2025 at Cellcronic Technologies Limited.
Yogesh Butta held 1 earlier board appointment: Liquid Gold Pharmaceuticals Private Limited (Director, 09 Nov 2020 to 10 Dec 2021).
The current boards of Yogesh Butta's companies include Anjali Sheoran (Cellcronic Technologies Limited), Ankur Sharma (Cellcronic Technologies Limited), Deepak (Cellcronic Technologies Limited), Ravinder Mandhan (Cellcronic Technologies Limited), Renu Kaur (Cellcronic Technologies Limited), Sumit Sharma (Cellcronic Technologies Limited), among others.